Sponsor Pipeline

Genovn Therapeutics (Suzhou) Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
Active Trials by Phase
Early Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Early Phase 1
NCT07621471 IL-15 Enhanced NK Cell Therapy for Solid Tumors Solid Tumors Not Yet Recruiting
Get alerts when Genovn Therapeutics (Suzhou) Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free